Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) – Research analysts at HC Wainwright decreased their Q2 2023 earnings estimates for shares of Aptose Biosciences in a research report issued on Monday, June 12th. HC Wainwright analyst J. Pantginis now anticipates that the biotechnology company will post earnings of ($3.07) per share for the quarter, […]
Aptose Biosciences Inc. (TSE:APS – Get Rating) (NASDAQ:APTO) – Stock analysts at HC Wainwright issued their Q2 2023 earnings estimates for shares of Aptose Biosciences in a report issued on Tuesday, May 9th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will post earnings per share of ($0.20) for the quarter. The consensus […]
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Equities research analysts at Cantor Fitzgerald reduced their FY2023 earnings per share estimates for shares of Aptose Biosciences in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Watsek now forecasts that the biotechnology company will post earnings of ($0.42) per share for the […]
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of recent ratings […]
Aptose Biosciences (NASDAQ:APTO – Get Rating) and Quince Therapeutics (NASDAQ:QNCX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Volatility and Risk Aptose Biosciences has a beta of […]